Are these test results normal if you're on a GLP-1 like semaglutide or tirzepatide

Understanding Blood Test Changes on GLP-1 Medications

As the founder of CFP Weight Loss and author of The CFP Code, I've guided thousands of patients aged 45-54 through sustainable weight loss while managing diabetes, blood pressure, and joint pain. GLP-1 medications such as semaglutide and tirzepatide produce predictable shifts in lab results that differ from typical “normal” ranges. These changes reflect the drugs’ powerful effects on appetite, insulin sensitivity, and fat metabolism rather than disease.

Expected Improvements in Metabolic Markers

Most patients see their A1C drop 1.5-2.0 points within 3-6 months on therapeutic doses. Fasting glucose often falls below 100 mg/dL even if you previously struggled with prediabetes. Lipid panels improve dramatically: triglycerides commonly decrease 20-40%, while HDL rises 5-10 points. LDL may dip modestly, though the real benefit comes from reduced small-dense LDL particles. These shifts explain why many finally control blood pressure and diabetes without extra prescriptions.

In The CFP Code, I emphasize tracking these wins to rebuild trust after repeated diet failures. Because insurance rarely covers these programs, seeing objective lab progress helps justify the investment for middle-income families balancing mortgages and medical costs.

Kidney, Liver, and Hormone Panels

eGFR often rises 5-10 mL/min as weight drops and blood pressure improves, but a temporary 10-15% creatinine bump in the first 4-8 weeks is common and usually harmless. Liver enzymes (ALT/AST) frequently normalize as fatty liver recedes. Thyroid numbers typically stay stable, yet many women notice better energy once insulin resistance eases, addressing the hormonal changes that made prior weight loss impossible.

Electrolytes can shift if gastrointestinal side effects limit fluid intake; mild drops in potassium or magnesium respond quickly to diet tweaks rather than complicated meal plans. Joint pain decreases for most within 10-15% body-weight loss, making movement realistic again without gym intimidation.

When to Contact Your Provider

Concerning flags include sustained heart rate above 100 bpm, severe nausea with dehydration, or rising lipase suggesting pancreatitis (rare, <1%). Persistent low blood sugar in those on insulin or sulfonylureas requires dose adjustment. I recommend quarterly labs for the first year, then biannual, paired with the simple CFP tracking system that fits busy schedules.

These medications break the cycle of diet failure by addressing root metabolic dysfunction. Combine them with the protein-first, resistance-focused approach in The CFP Code and most patients lose 15-20% of body weight while improving every major lab marker. The results you’re seeing are not only normal—they’re expected when the medication is working.